Providing Immediate CD4 Count Results at HIV Testing Improves ART Initiation
- 1 November 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 58 (3), e54-e59
- https://doi.org/10.1097/qai.0b013e3182303921
Abstract
In South Africa, CD4 count results are typically available within a week of testing. However, 35%-55% of newly diagnosed HIV-positive patients do not return for their CD4 results and therefore, do not access further care. We evaluated the impact of a CD4 count result and patient written information provided immediately after diagnosis on retention in care. HIV-infected subjects were randomized to 3 arms; receipt of a CD4 result at time of HIV diagnosis, receipt of written information, and standard of care (CD4 collection after 1 week) or standard of care alone. The outcome of interest was enrollment for further care within 1 month for pre-antiretroviral therapy (ART) care or within 3 months for ART initiation. Secondary outcome was time taken from diagnosis to each stage of care pathway. Independent predictors of retention were assessed with multivariate analysis. Three hundred forty-four patients recruited, of which 64.5% were females with a median age of 30 years (interquartile range: 27-35). Subjects were similar in age, gender, CD4 count, education, and employment status. Providing CD4 results at HIV diagnosis increases the likelihood of reporting for ART initiation (risk ratio = 2.1; 95% confidence interval = 1.39 to 3.17) compared with standard of care. Written information only reduced the time to presentation for pre-ART care although increasing age was associated with retention. There was 49% attrition in the standard of care arms. Receipt of a CD4 count at the time of HIV testing increases ART initiation rates. Point-of-care diagnostics can be used to improve retention, but losses to pre-ART care remain high.Keywords
This publication has 13 references indexed in Scilit:
- Cost of using a patient tracer to reduce loss to follow‐up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South AfricaTropical Medicine & International Health, 2010
- The “ART” of Linkage: Pre-Treatment Loss to Care after HIV Diagnosis at Two PEPFAR Sites in Durban, South AfricaPLOS ONE, 2010
- Who starts antiretroviral therapy in Durban, South Africa?… not everyone who shouldAIDS, 2010
- Loss to Follow-Up of Adults in Public HIV Care Systems in Central Mozambique: Identifying Obstacles to TreatmentJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan AfricaAIDS, 2008
- New BD FACSCount™ CD4 reagent system for simultaneous enumeration of percent and absolute CD4 T-lymphocytes in HIV-1-infected pediatric patientsCytometry Part B: Clinical Cytometry, 2008
- Large-scale affordable Panleucogated CD4+testing with proactive internal and external quality assessment: In support of the South African national comprehensive care, treatment and management programme for HIV and AIDSCytometry Part B: Clinical Cytometry, 2008
- African regional external quality assessment for CD4 T-cell enumeration: Development, outcomes, and performance of laboratoriesCytometry Part B: Clinical Cytometry, 2008
- Characteristics and Outcomes of Adult Patients Lost to Follow-Up at an Antiretroviral Treatment Clinic in Johannesburg, South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic ReviewPLoS Medicine, 2007